Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Just click your heels together...it will all be over soon
Never knew you were one to worry about facts? Turning a new leaf?
This time will be different...very different!
I've never understood the mentality of people to attack something that can save lives or better society. Whether it be a cancer drug, a safety device or whatever. Simply makes no sense to me. WTBS, we live in soceity that is all about self serving empowerment even at the detriment of others and things that might improve society and the human condition.
We are rotting from the inside out as a people and it seems many enjoy it. It's all about money, power, prestige etc....I have to wonder, when you breathe your final breath, will all that have even mattered? Will it matter to your kids, your loved ones, your God?
I think not.
May "he" be a lamp unto your feet and a light unto your path.
Is it the Special Selection?
I plan on breaking into some 2007 Heitz Martha's Vineyard I've been sitting on for about 12 yrs
You ain't seen nothin' yet!!
GLTA
Ouch...the ole' compare against historical norms seems to have struck a cord.
To be on the safe side, better close up that short position!!
GLTA
Agreed...release of TLD and publication will be seperate and before ASCO. But it will certainly all be discussed at ASCO
My quess would be to "stay quiet"
Great interview with Dr Pazdur who once again gives insight as to the mindset of the FDA from a regulatory standpoint.
"What is in the best interest of the patient when making a regulatory decission."
https://ocrahope.org/2022/04/ocra-in-conversation-dr-richard-pazdur-fda/ (gets good at the 16:30 point)
posted 4/20/22
Understanding better the biology and immunology of the disease...Hmmm. So maybe the new WHO classification of Gliomas along with advances in biomarkers is allowing "us" to better understand the disease and in doing that, we can make better informed decissions about what "drugs" can have a benefit, even if only for certain subtypes.
GLTA
Yah...AF's approach to bashing MANY Biotech Co's and his apparent success rate of calling out anticipated failed trials is brilliant for a Poli Sci Majo in light of this statistic:
Immuno-oncology therapies provide a rare pocket of success in oncology R&D with an overall LOA of 12.4% vs 5.3% for all oncology approaches.
The Col. Jessup of Biotech...LOL
It certainly will be Grand and you know what they say about ASS-U-MEing.
What would constitute real data for Mr Ex"wannabe"?
If there is overwhelming support for the REAL data that is about to come out by experts in the field...what will Ex"wannabe" have to say then?
This is gonna be fun!!
GLTA
Bring the Ramen
What a positive outlook!!
GLTA
Looky there
Session 4: Panel Discussion
4:00 PM-5:00 PM
4:00 PM
How to Change a Cold Tumor to a Hot Tumor?
Moderator & Panelists: To be announced
You may want to enlighten yourself with this article:
https://khn.org/news/article/dying-patients-with-rare-diseases-struggle-to-get-experimental-therapies/
You seem to think this is just an NWBO/GBM issue when in fact it is industry and regulatory issue.
All arrows point the the archaic pathway for FDA approval of rare, deadly diseases with an unmet need are changing and IMO, NWBO will benefit from these changes.
GLTA
“I don't know half of you half as well as I should like; and I like less than half of you half as well as you deserve.”
This looks like an interesting line up on May 10th: https://events.nyas.org/event/28ca5e39-51a7-4e73-be3d-78089c92d596/websitePage:ccf12eed-4b47-487c-82af-faa589df6e0a
Session 5: Unique Challenges in Emerging Immunotherapies
9:00 AM-10:40 AM
9:00 AM
Welcome Remarks
Barbara Knappmeyer, PhD, The New York Academy of Sciences
Session 6: Unique Challenges in Emerging Immunotherapies
Session Chair: To be announced
9:10 AM
Immune Checkpoint Blockade in Glioblastoma
David Reardon, MD, Dana Farber Cancer Institute
9:40 AM
How Do CAR T Cells Kill Cancer?
Marcela V. Maus, MD, PhD, Massachusetts General Hospital, Harvard Medical School
10:10 AM
Immunotherapeutic approaches to Glioblastoma Treatment
Vinay K. Puduvalli, MD, MD Anderson Cancer Center
Networking Break
10:40 AM-11:10 AM
Session 6: Unique Challenges in Emerging Immunotherapies (Continued)
11:10 AM-12:10 PM
11:10 AM
Autologous Tumor Lysate-loaded Dendritic Cell Vaccination for Glioblastoma
Linda M. Liau, MD, PhD, University of California, Los Angeles
11:40 AM
Independent Drug Action in Immunotherapy: Implications for Drug Discovery and Precision Medicine
Peter Sorger, PhD, Harvard Medical School
Grand Canyon University
Proud Papa for sure!
Noted and in order!
Hang in there Flip!!
Our oldest daughter will be attending a private school in Phoenix this year and our son wants to go to NAU (Flagstaff) next year so we will most likely be getting a small condo in Scottsdale this Fall (great golfing). It will be nice reprieve during the long winter months whether in Bend or Sandpoint.
Cheers!
Great minds think alike
BTW, will be visiting Sandpoint for a week this summer. Thinking of buying some land there and once we are empty nesters, we would build. Loving Bend, OR but it has gotten really busy here
Absolutely Brother!!
GLTA
Can't convince me!
Sorry you are feeling like your patience in this has come to an end..truly!
You have been an invaluable contributor to this board and I know many here would 2nd this.
Hope you find a way to stick around thru ASCO.
Perhaps b/c there are many of us who have been here for 8+ yrs, we know what we have all been through (highs/lows) with NWBO and maybe some of us care about eachother.
I get the frustration and need to vent but I truly do beleive we are at the finish line. It would be a shame to see certain posters who have contributed so much to this board such as Flip, loose their patience and bail just before news that we have all been waiting for for the past 4yrs.
GLTA
Sounds reasonable. If ASCO comes and goes I will also consider offloading some shares but I really don't believe that will be the case IMO.
GLTA
Impeccable timing from the not so passive investor.
GLTA
Yah...you sure seem like it. Weird that this "turd" that I'm invested in I'm currenlty up over $120K and I can assure you while this "turd" floats you're about get sunk.
Good to see you're happy though given you're not invested apparently. Is your boss?
Happy, Are We Allowed To Say Clockwork?
Like Clockwork Too predictable